The Future of MRI in Prostate Cancer
In Partnership With:
Andrew Vickers, PhD, attending research methodologist at Memorial Sloan Kettering Cancer Center, discusses the future of MRI in prostate cancer.
Andrew Vickers, PhD, attending research methodologist at Memorial Sloan Kettering Cancer Center, discusses the future of MRI in prostate cancer.
Vickers says that steps should be taken to improve MRI so that it can be a tool that provides a high and consistent negative predictive value.
Another idea being discussed in the space is risk stratification prior to MRI, Vickers adds.
Clinicians referring a patient to MSK can do so by visiting msk.org/refer, emailing referapatient@mskcc.org, or by calling 833-315-2722.
Related Videos
Related Content
